Our researchers are in process of discovering predictive biomarkers that can be used in early pregnancy to identify women who are at high risk of developing preeclampsia, which will allow doctors and patients to personalize pregnancy care and improve outcomes.
Our researchers use mouse models in order to study the development of the placenta, to probe the contributions of placenta to fetal health and growth, and to evaluate the role of maternal obesity and metabolic disease on programming of health and disease in the offspring.
Our research group uses a multi-prong approach to study the impact of pregnancy and parturition on the structure, function, plasticity, and regenerative potential of the female pelvic soft tissues.
A major initiative of the Center for Perinatal Discovery will be FAMILIA, in which we plan to recruit 1000 women prior to conception or during the first trimester of pregnancy and collect clinical data and biosamples before, during, and after pregnancy.
Our researchers have developed a method by which cells from the placenta at delivery can be reprogrammed first into “induced pluripotent stem cells” (iPSC’s) and subsequently differentiated into TSC’s.
This project aims to identify factors that are associated with IVF success. Our researchers have studied early embryos at the blastocyst stage of development.
Our Center comprises of pediatric and perinatal pathologists who routinely perform detailed placental and post-mortem fetal and neonatal examinations (autopsies), and work closely with genetic counselors and colleagues in Obstetrics, Neonatology, and Radiology, in order identify causes of pregnancy loss and neonatal mortality.
Our researchers are studying the relationships between bacterial community structure, carbohydrate breakdown and pregnancy outcomes such as preterm birth.